Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/5/18 → 12/31/20 |
Funding
- Janssen Pharmaceutical Research and Development: $9,335.46
Protocol 63623872FLZ3002: A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and Elderly Non-hospitalized
- Rupp, Richard (PI)
Project: Research project